Improved access to induced pluripotent stem cells for allogeneic cell therapy applications SEATTLE — Pluristyx, Inc., an advanced therapy tools and services biotechnology company, panCELLa, a privately held biotechnology company, and Implant Therapeutics, a developer of genetically engineered stem cells, today announced they have entered into a manufacturing and distribution strategic alliance that offers cell […]
Collaboration will enable transparent, cGMP, and scalable manufacture of custom cell culture media Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a collaboration agreement on custom media formulation and fulfillment solutions for the cell and gene therapy industry. Utilizing Nucleus Biologics’ proprietary platform, Cytiva customers will have […]
Partnership will optimize manufacturing of extracellular vesicles (EVs) using scalable and continuous bioprocessing technologies to propel the commercialization of regenerative therapies at affordable costs. Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms RoosterBio to leverage scalable, continuous bioprocessing technologies to deliver regenerative therapies at reduced timelines and costs, […]
Cytiva welcomes Nucleus Biologics’ proven and powerful AI-powered interface that brings state-of-the-art cell media design and supply to the Cell and Gene Therapy Industry. Cell and gene therapies are critically reliant on the growth and maintenance of a viable and efficacious cell population. It is proven that cell culture media can have a profound impact […]
Ms. Moy brings 30 years of HR leadership experience at high-performing companies MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Marilee Moy as Chief People Officer. Ms. Moy has more than 30 years of HR leadership experience at high-performing life sciences and technology companies. She […]
Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms. RoosterBio to leverage scalable, continuous bioprocessing technologies to deliver regenerative therapies at reduced timelines and costs, improving access for patients. FREDERICK, Md. — Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable viral production, announces today […]
Corning 3D solutions, including the company’s new Matribot® bioprinter, support life science innovation in areas including drug screening and precision medicine CORNING, N.Y. – Corning Incorporated will highlight its latest technologies that support the advancement of 3D cell culture and drug discovery at this year’s Society for Laboratory Automation and Screening (SLAS) conference in Boston […]
~ The DISC™ device releases FGF2 at a controlled rate, minimizing variations in concentration and providing stable FGF2 levels with improved control for higher quality cultures ~ Controlled levels of FGF2 reduce spontaneous differentiation, enhance pluripotency and improve the differentiation efficiency of stem cell cultures. RENSSELAER, New York – StemCultures, a life sciences company developing […]
LAUSANNE, Switzerland – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the appointment of Janis M. Taube, M.D., M.Sc., a leading pathologist and expert on immunotherapy research, to its Scientific Advisory Board. As an advisor, Dr. Taube will provide strategic advisory support to Lunaphore’s scientific activities and product […]
Following the recent launch of Dolomite Bio’s RNAdia kit for single cell research. Dolomite Bio is now launching a Bioinformatics Service, which can be purchased alongside the kit as simply as if you were buying reagents. With upfront costs, allowing for easy forecasting, cost-effective and hassle-free single cell RNA-Sequencing. Data analysis is an essential part […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
